RASAL2 and breast carcinoma: Apparently, phosphorylated RASAL2 facilitates breast cancer progression and the ratio of p-RASAL2/non-p-RASAL2 is one of the determining factors for the effect of RASAL2 in ER+ and ER- breast cancer 17, 26.